Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Medication Use During Pregnancy

Asthma Management

  • The American Academy of Allergy, Asthma, and Immunology recommends montelukast for recalcitrant asthma during pregnancy, particularly in patients who have shown favorable response prior to pregnancy 2
  • Montelukast can be continued or initiated for recalcitrant asthma during pregnancy, particularly in patients who have shown favorable response prior to pregnancy 2
  • Inhaled medications have been used for many years without documented adverse effects on the fetus, making them preferred first-line options for asthma control 2, 4
  • Poorly controlled asthma poses greater risks to maternal and fetal health than medication use 2

Allergic Rhinitis Management

  • The American Academy of Allergy, Asthma, and Immunology recommends avoiding levocetirizine during the first trimester if possible 1
  • Cetirizine and loratadine have more accumulated safety data than levocetirizine and should be preferred 1
  • For antihistamine treatment during pregnancy, chlorphenamine, cetirizine, or loratadine are preferred due to their established safety records 1
  • Intranasal corticosteroids or sodium cromolyn may be preferred options for allergic rhinitis during pregnancy 1, 2

Breastfeeding Considerations

  • About 1% of montelukast passes into breast milk, but extensive metabolism and plasma protein binding are thought to limit infant exposure 2
  • Excretion of montelukast into breast milk is very low 3
  • For nursing mothers using montelukast, the benefits of breastfeeding generally outweigh the risk of exposure; consider breastfeeding prior to medication intake to further limit exposure 2

General Considerations

  • Limited data suggest no significantly increased risk of malformations with montelukast use during pregnancy, but the number of exposed women is insufficient to ensure complete safety for the fetus 3
  • When considering medication use during pregnancy, balance maternal risk of therapy versus no therapy and the fetal risk of uncontrolled maternal disease with the risk of therapy on the newborn 4
  • Assuming all antihistamines have equivalent safety profiles during pregnancy is a common pitfall 1
  • Regular monitoring of asthma control is essential during pregnancy 2

REFERENCES

1

Montelukast Safety During Pregnancy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Safety of Montair LC During Pregnancy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Safety of Montek LC Kid in First Trimester Pregnancy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025